Resumo

MARTINEZ, María Inés et al. Expert recommendations on the use of teduglutide in pediatric patients with short bowel syndrome. Medicina (B. Aires) [online]. 2023, vol.83, n.1, pp.114-121. ISSN 0025-7680.

Short bowel syndrome is a low-incidence disorder among pediatric patients, but it is associated with high morbidity and mortality rates. Management of these patients by an interdisciplinary team of experts focused on intestinal rehabilitation improves short- and long-term outcomes. Available resources for treatment include teduglutide, a glucagon-like peptide type 2 (GLP-2) analog made by recombinant techniques. Considering the available evi dence and the authors’ experience, Delphi-based recommendations for the use of teduglutide are suggested for healthcare professionals who treat pediatric patients with short bowel syndrome, as well as for health authorities.

Palavras-chave : Short bowel syndrome; Glucagon-like peptide 2; Parenteral nutrition; Delphi method.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )